Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07853742 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Omadacycline for Treatment Refractory Mycoplasma Genitalium Urethritis

StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Urethritis from Mycoplasma genitalium is difficult to treat and often does not respond to first line therapy. In this case series study, individuals who have failed first line therapy will receive omadacycline (provided by Paratek Pharmaceuticals) to determine the safety and feasibility of using this agent for this condition.
Trial Details
NCT Number NCT07853742
Lead Sponsor Montefiore Medical Center
Collaborators: Paratek Pharmaceuticals Inc
Conditions
(from sponsor)		 Mycoplasma Genitalium Infection, Urethritis
Related terms Urethritis
Enrollment 10 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov